FINAL DIAGNOSIS: camper»:

PART 1‘: rumour, TOTAL Tmnomacromae omsI— 2 so #2 M at! w T3"-
A. PAPILLARY THYROID IIIcnocAncmouA. TALL CELL VARIANT (0.3 cm acumen To THE LEFT Loss.
3. METASTA‘IIC OYSTIC FAPiLLARY THYROID CARCINOMA lN LYMPH N003. mums; MICROSCOPIC

- summon. EXTENSION PRESENTIIIle ml).
C. FAMOLOGIC STAGE: pTil Nil.

PART 2: LYMPH MODES, CENTRAL OOHPARTMENT. SELECTIVE NECK DISSECTION -

A. METASTATIC PAPILLARY THYROID CARCINOMA IN ONE OF ONE LYMPH MODE (1"); NO WODAL
EXTENSION.

a. uunmnnmu: THYROID nssua. ‘ r
c. SPECIMEN ENTIRELY suaumeo FOR HIsTOLooIc EVALUATION.

COMMENT:

I
The worm nodule that was pmrouuy aspirated ”an a law ImI arm: mutation mom I. In Im an
ohms-named lymph node in Port 1. '

Tho pronumod primary tumor II a 0.3 cm mlmolnomo. tall call variant with alwan ilbroolo. though not subcapoular
In location. Molncuiar ruling on this loom wil be perfumed and mm In an addondum.

§

CASE SYNOPSIS:
SIESI'M'e': 33:25 "' "M“ m "' "”33"”de m ”um:IEZ‘iféglFiﬁgiﬁfﬂi‘: ’97F8F3F’7ﬁ7e‘da cted
m - L T“ ’ ||||||
mmggium ﬁn? ||| |||||IIIIIIIIIIHIIII||||||||||||||||||||||| |||||||||||||
ﬁﬁgﬁ'ﬁwmw gémwﬂﬁmmm I“ III llHHllllllll|||||||||||||||l ||||||||||||||||
mummuomm: pm ' III||||||||||||||||||||||||||||||| ||||||||||||I|| |||||||||||
REGIONAL mam moss (pH): pNIa .
' Number of regional lymph node. examined: 2 I
_ ‘ ' ‘ Numberofmglonnllymphnodosimoivodﬂ ICb-O ,3
urgeé‘TLAsnsrs (93» ’ Emma: ‘ . “ r to“
2%THYROIDAL EXTEPNSION: ‘ Not Iqenmd ' CW; W l “‘3 , ﬁll
mswﬁscuun INVASION: 3E1? uninvolved by mm“ Ila/WM ‘75 4‘” 3
W. I._. Srqu M54, NOS (373-9
MOLECULAR AriATomc PATHOLOGY TESTING: ‘ ‘ ,
Block 1| (THY'ROID. LEI-'IT LOBE. PAPILLARY THYROID MICIrOCARCINOMA. 0.3 cu):
. . A. BRAF mm“ IIJENTIFlEprNeDoE. whom). ’ ' (WM/0'
AB. Human: In NRAsoI. HRAsor, msrz/ra and RET/Prcr and RETIP'I’C3 rearrangements
NOT id-nurled.
NOTE: ' . ’
Nuclolc acids won am In ﬂTI'arlIoum willow-i for who.
BACKGROUND: ‘ '

Murmurs ineither BRAFor RAS genes or RET/PTCroarrangamenis Ire-found In more than 70% of papillary lhyror'd carcinomas -
(1 ). BRAF WOOE (T1799A) mulalion has been iasoaclaled wllhmoro aggraulvo behavior oi papillary carcinoma (2. a). The
assoclaﬂon Ween BRAFVGOOE maiden and natures of tumor aggressiveness have also boon observed in paplllary
Mmmm (4). Mutations In the R65 gone. or PAXGIPPARQ rearrangement occur in ~70% of iblllouiar myrold carcinomas
and wiih lower frequency Inroneocyiic (Hﬂrthlq cell) carcinoma. (5). Regarding tho speciﬁcity of then mutaﬂons for cancer. BRAF
V6005 mulaiion and RET/PTC and PAXII/PPARg rearrangements are overall speciﬁc for malignmcy In lire thyroid, although may
havobeen reportodwlﬂr averylow lmquancyln benign Wold MINING). R45 muinﬂom ooourin mailgnantand benign thyroid
Mindoro. beingiound In «10-60% of follicular and anaplaoilo carcinomas. 30—40% of folllcuiar adenomas and 10-15% of papillary
ca nomas . ‘ ‘“
1r AMMAI. old. Wummmmwmmmmmm aroma-Imam d
WW MgNnJ Sum Patna! 2008. 30:216-222

2 xlng M, vial. Wmalmpradbunmcﬂrﬁcdnmgmohfarmﬂmuﬂm JCilrIEndoainoiMoiobzaoo, scram-0379.

1 EJmIR. oiaI. EMF vmmmmummnmmmmmu iammdcnbm-up study. JCiin
Elm mm 2005. mm

4. LeoXGaoMJlY, YuY._Feng Y.UY.ZIIarIg Y,mmwmwdewAmeMmmmhmwm
pmwmmmmmmsmm mmrammo-G.

5 NMWb'MMbial RASNMMWWAXWMyNWhWWmem-wwpmah
(hymid'falllculwma- ,JCM EndoainoIMoM 2003. 8&2318-26.

a NMherE..dewlopmmmm.mbwlnualogyolimmyrm ln:ondRV., 9d. EndoaimPnﬂnbngonnlllengrmmd
maul/mm. Humans. Tom. 2004, 191-200.

MUTATION“; ANALYSIS:

Forum. '_ ruonwespermrmdlocoﬂodlumordaouo. Snodmenswilhﬂ'nmwmumdm

, > , _ I WMNWMWWMPCRWNMWM
Imwmrom _. mommimeaswgimmsmnm,WKRASooqomIZ/iasoomm Post-FOR
minerauwwmsmusodlodoiodmmmmSlngb-slopmaﬁimﬂfmmpwfumdloompﬁymwmmd "

ﬁydwogmmmmmm 7haWdﬁWBW10-Zmddlohswlhmumro
and

     
  

Friar Mahgmnﬂ lﬁalow
ﬁnal/vaiclﬂnruilfrimary Noled
(as: is [cirL'Inji
~—

 

